GPC3 mutations in seven patients with Simpson–Golabi–Behmel syndrome

We analyzed mutations of the GPC3gene in seven males with typical manifestations of Simpson–Golabi–Behmel syndrome (SGBS). Genomic DNA was PCR amplified for its all eight exons and exon–intron boundaries using designed set of primers, and PCR products were directly sequenced. All seven males studied had mutations: One patient had a large deletion spanning introns 6 and 7, four each had a C → T base substitution resulting in a stop codon formation in exons 2, 3, and 4, one had a single‐base insertion in exon 2, and the other had a six‐base deletion and a three‐base insertion in exon 3; all resulting in loss‐of‐function of the glypican‐3 protein. These results, together with previous studies of GPC3 mutations, indicate that there is no hot spot for GPC3 mutations or deletions in the patients with the syndrome. Also, no correlation has been noted between the location and nature of mutations and the phenotype of the patients studied, as is the case of the present study. © 2007 Wiley‐Liss, Inc.

[1]  P. Lapunzina,et al.  Clinical and molecular studies on two further families with Simpson‐Golabi‐Behmel syndrome , 2005, American journal of medical genetics. Part A.

[2]  P. Lapunzina Risk of tumorigenesis in overgrowth syndromes: A comprehensive review , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[3]  R. Bertorelli,et al.  Genotype/Phenotype Correlations of Males Affected by Simpson-Golabi-Behmel Syndrome with GPC3 Gene Mutations: Patient Report and Review of the Literature , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  R. Weksberg,et al.  GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. , 2001, American journal of medical genetics.

[5]  J. Fryns,et al.  Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. , 2000, Human molecular genetics.

[6]  Y. Wada,et al.  A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome , 1999, Journal of Human Genetics.

[7]  A. Mackenzie,et al.  A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family , 1999, Journal of medical genetics.

[8]  D. Schlessinger,et al.  Gpc3 expression correlates with the phenotype of the Simpson‐Golabi‐Behmel syndrome , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  P. Marynen,et al.  GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. , 1998, Genomics.

[10]  R. Mazzarella,et al.  Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene. , 1997, Genomics.

[11]  D. Schlessinger,et al.  Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. , 1997, Journal of medical genetics.

[12]  D. Schlessinger,et al.  Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. , 1996, American journal of medical genetics.

[13]  D. Schlessinger,et al.  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome , 1996, Nature Genetics.

[14]  R. Weksberg,et al.  Infantile lethal variant of Simpson-Golabi-Behmel syndrome associated with hydrops fetalis. , 1995, American journal of medical genetics.